Case Studies
Industry
The fast-tracking of mRNA-based vaccines in the face of a real-life global pandemic has been a revelation and one which has opened up possibilities for harnessing mRNA products against a wide range of viruses. The race is now on to develop the next generation of mRNA therapeutics using machine learning and AI techniques for target identification, and the integration of full digitization tools into user-friendly platforms could present significant advantages.
Stepping into this arena is US-based biotechnology company Translate Bio, headquartered in Lexington, Massachusetts, specializing in mRNA products and co-developing vaccines with collaborator Sanofi Pasteur. Its data science manager, Emma McIntosh, has begun organizing the company’s data flows and implementing electronic lab notebooks that bring a whole host of efficiency benefits and help with regulatory compliance.
Learn how Translate Bio (now acquired by Sanofi) uses eLabJournal to speed the development of mRNA-based vaccines.
> Read the full article on SelectScience
What stuck out about the eLabJournal software is that it was so easy for people to lift their process from saving their information to a shared drive to saving it all into an electronic lab notebook.
Emma McIntosh
Learn how eLabInventory has strengthened sample management at HistologiX, streamlining processes and improving efficiency for better research outcomes
Read more
Learn how eLabNext transformed sample management at Lund University, reducing search and retrieval times from hours to minutes.
Read more
Discover how Myllia Biotechnology GmbH revolutionised their lab operations and enhanced research efficiency with eLabNext.
Read more
Schedule a Personal Demo for friendly expert guidance and a free lab workflow assessment.
ENG 
DE 
FR